After cardiac stenting, the appearance of ecchymosis in the skin is considered to be caused by antiplatelet drugs, and should be timely to the hospital to improve the coagulation examination.
After cardiac stenting, antiplatelet therapy is needed to prevent blood clots, and the routine medication is double antiplatelet aggregation drugs, such as aspirin combined with clopidogrel or aspirin combined with tegretol. Skin bruising is easy to appear after taking the drugs, which should be consulted in the hospital in a timely manner, and blood routine and coagulation tests should be completed.
If the bruise area is small and the test results are not abnormal, you can continue to take the above drugs; if the bruise area is large or the test results are abnormal, you should change the drug or reduce the dosage under the guidance of the doctor.
There is also a possibility that one’s own disease, such as thrombocytopenic purpura, can also be manifested as skin bruises, which should be clarified by actively improving the bone marrow examination.